Cargando…
Blood glucose levels and bodyweight change after dapagliflozin administration
AIMS/INTRODUCTION: Increased blood glucose or increased weight is often observed in patients who are prescribed sodium–glucose cotransporter 2 inhibitors (SGLT2i). The aim of this study was to determine in advance which patients, among those prescribed a SGLT2i, would be likely to have improved or w...
Autores principales: | Kim, Hyunah, Lee, Seung‐Hwan, Lee, Hyunyong, Yim, Hyeon Woo, Cho, Jae‐Hyoung, Yoon, Kun‐Ho, Kim, Hun‐Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409884/ https://www.ncbi.nlm.nih.gov/pubmed/33522718 http://dx.doi.org/10.1111/jdi.13516 |
Ejemplares similares
-
Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
por: Jun, Hye-Ran, et al.
Publicado: (2021) -
Retrospective cohort analysis comparing changes in blood glucose level and body composition according to changes in thyroid‐stimulating hormone level
por: Kim, Hyunah, et al.
Publicado: (2022) -
Characteristics of Hypoglycemic Diabetic Patients Visiting the Emergency Room
por: Kim, Tong Min, et al.
Publicado: (2020) -
Long-Term Changes in HbA1c According to Blood Glucose Control Status During the First 3 Months After Visiting a Tertiary University Hospital
por: Kim, Hyunah, et al.
Publicado: (2022) -
Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence
por: Lee, Jeongmin, et al.
Publicado: (2020)